Perinatal haemolytic disease. Part 2: Prevention and management;Maladie hemolytique perinatale 2(e) partie: Prevention et prise en charge

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 27, Issue 3, 1998, Pages 265-276

  Hohlfeld, P ^a   Wirthner, D ^a   Tissot, J D ^b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b Fondation Ctr de Transfus S   (Switzerland)

Author keywords

Fetal blood sampling; Fetal hemolytic disease; Intravascular transfusion; Prenatal diagnosis

Indexed keywords

RHESUS D ANTIBODY;

AMNIOCENTESIS; ANTIBODY DETECTION; FETUS BLOOD; HEMOLYTIC ANEMIA; HUMAN; INTRAUTERINE BLOOD TRANSFUSION; NEWBORN; PERINATAL MORBIDITY; PRENATAL SCREENING; REVIEW; ALGORITHM; DECISION TREE; METHODOLOGY; NEWBORN HEMOLYTIC DISEASE; POSTNATAL CARE; PRENATAL DIAGNOSIS;

ALGORITHMS; DECISION TREES; ERYTHROBLASTOSIS, FETAL; HUMANS; INFANT, NEWBORN; POSTNATAL CARE; PRENATAL DIAGNOSIS; RHO(D) IMMUNE GLOBULIN;

EID: 0032036864     PISSN: 03682315     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (126)

1. Bowman JM. Haemolytic disease of the newborn. In : Bowman JM, ed. Baillère's clinical immunology and allergy. London, Baillère Tindall, 1987:391-425.
2. Daffos F, Forestier F. Maladies immunologiques. In : Médecine et biologie du fœtus humain. Paris, Maloine, 1993:241-52.
3. Rodeck CH, Letsky EA. How the management of erythroblastosis fetalis has changed. Br J Obstet Gynaecol 1989;96:759-63.
4. Hamilton E. Prevention of Rh isoimmunization by injection of anti-D antibody. Obstet Gynecol 1967;30:812-5.
5. Freda VJ, Gorman JG, Pollack W, Bowe E. Prevention of Rh hemolytic disease. Ten year's clinical experience with Rh immune globulin. N Engl J Med 1975;292:1014-6.
6. Pollack W, Singher HO, Gorman JG, Freda VJ. The prevention of isoimmunization to the Rh factor by passive immunization with Rho [D] immune globulin [Human]. Haematologia 1968;2:1-8.
7. Stem K, Goodman H, Berger M. Experimental isoimmunization to hemoantigens in man. J Immunol 1961:87:189-98.
8. Bowman JM. Controversies in Rh prophylaxis. Am J Obstet Gynecol 1985;151:289-94.
9. Samson D, Mollison PL. Effect on primary Rh immunization of delayed administration of anti-Rh. Immunology 1974;28:349-57.
10. Hohlfeld P, Tissot J-D, Schneider Ph, Vial Y, Maillard-Brignon C, Schmidt PM et al. Les transfusions intra-utérines dans le cadre des maladies hémolytiques fœtales. Méd Hyg 1992;50:1229-34.
11. Monestier M, Rigal D, Juron-Dupraz F, Meyer F. Maladies hémolytiques du nouveau-né par allo-immunisations maternelles contre les antigènes érythrocytaires autres que A, B, et Rhésus D. J Gynecol Obstet Biol Reprod 1984;13:671-80.
12. Moncharmont P, Juron-Dupraz F, Vignal M, Rigal D. Dépistage systématique de l'allo-immunisation antiérythrocytaire au cours de la grossesse. J Gynecol Obstet Biol Reprod 1989:18:321-4.
13. Frère MC, Schaaps JP, Thoumsin H, Retz MSC, Rif J, Rigo J et al. Maladie hémolytique fœtale à développement rapide et sévère due à un anti-Kell. Rev Med Liege 1995;50:63-6.
14. Hardy J, Napier JAF. Red cell antibodies detected in antenatal tests on Rhesus positive women in south and mid Wales, 1940-1978. Br J Obstet Gynaecol 1981;88:91-100.
15. Heddle NM, Klama L, Frassetto R, O'Hoski P, Leaman B. A retrospective study to determine the risk of red cell alloimmunization and transfusion during pregnancy. Transfusion 1993;33:217-20.
16. Palmer A. Red cell antibodies. Br Med J 1987;294:1568-9.
17. Freda VJ, Pollack W, Gorman JG. Rh disease: How near the end? Hosp Pract 1978;june:61-9.
18. Ness M, Salamon L The failure of postinjection Rh immune globulin titers to detect large fetal-maternal hemorrhages. Am J Clin Pathol 1986;85:604-6.
19. Poulain M, Huchet J. Appréciation de l'hémorragie fœtomatemelle après accouchement en vue de la prévention de l'immunisation anti-D (bilan de 5 488 tests de Kleihauer). Rev Fr Trans 1971;14:219-24.
20. Woodrow JC, Donohue WTA. Rh-immunisation by pregnancy: Results of a survey and the relevance to prophylactic therapy. Br Med J 1968;4:139.
21. Kenneth J. Changing trends in the management of red blood cell alloimmunization in pregnancy. Arch Pathol Lab Med 1994;118:421-8.
22. Letsky EA. Preventing Rh immunization. Br Med J 1994;309:213-4.
23. Bowman JM. Suppression of Rh isoimmunization, a review. Obstet Gynecol 1978;52:385-93.
24. Tovey D, Townley A, Stevenson J, Taverner J. The Yorkshire antenatal anti-D immunoglobulin trial in primigravidae. Lancet 1983;2:244-6.
25. Bowman JM, Chown B, Lewis M. Rh-immunization during pregnancy : antenatal prophylaxis. Can Med Assoc J 1978;115:623-7.
26. Richard Lee G, Bithell TC, Foerster J, Athens JW, Lukens JN. Alloimmune hemolytic anemias. In : Wintrobe MM, ed. Wintrobe's clinical hematology. 9th ed. Malvern : Lea & Febiger, 1993:1151-63.
27. Duerbeck N, Seeds JW. Rhesus immunization in pregnancy: a review. Obstet Gynecol Surv 1993;48:801-10.
28. Quartier P, Floch C, Meier F, Fruchart M-F, Brossard Y, Lejeune C. Hémorragie foeto-maternelle massive et prévention de l'incompatibilité Rhésus fœto-maternelle. J Gynecol Obstet Biol Reprod 1993;22:517-9.
29. Duguid JK, Bromilow IM. Value of Kleihauer testing after administration of anti-D immunoglobulin. Br Med J 1994;309:240.
30. Goto S, Nishi H, Tomoda Y. Blood group Rh-D factor in human trophoblast determined by immunofluorescent method. Am J Obstet Gynecol 1980;137:707-12.
31. Nicolaides KH, Rodeck CH. Rhesus disease: The model for fetal therapy. Br J Hosp Med 1985;34:141-6.
32. Liley AW. Intrauterine transfusion of fetus in haemolytic disease. Br Med J 1963:2:1107-9.
33. Valenti C. Antenatal detection of hemoglobinopathies. Am J Obstet Gynecol 1973;115:851-3.
34. Pellet B, Chessex D, Schneider Ph, Hohlfeld P. Allo-immunisations Rhésus à faibles titres et autres allo-immunisations en cours de grossesse. Rev Med Suisse Romande 1991;111:693-9.
35. Swinhoe DJ, Gilmore DH, McNay MB, Whittle MJ. Rh haemolytic disease : continuing problem of management. Arch dis Child 1990;65:365-8.
36. Nicolaides KH, Rodeck CH. Maternal serum anti-D antibody concentration and assessment of rhesus isoimmunisation. Br Med J 1992;304:1155-6.
37. Bowman JM. The management of Rh-isoimmunization. Obstet Gynecol 1978;52:1-16.
38. Parer J. Severe Rh isoimmunization. Current methods of in utero diagnosis and treatment. Am J Obstet Gynecol 1988;158:1323-9.
39. Judd WJ, Luban NLC, Ness M, Silberstein LE, Stroup M, Widmann FK. Prenatal and perinatal immunohematology: recommandations for serologic management of the fetus, newborn infant, and obstetric patient. Transfusion 1990;30:175-83.
40. Branch DW, Scott JR. Isoimmunization in pregnancy. In : Gabbe S, Niebyl J, Simpson J, eds. Obstetrics. Normal and Problem Pregnancies. New York, Churchill Livingston, 1986:793-817.
41. Wax J, Blakemore KJ. Fetal blood sampling. In : Blakemore K, ed. Obstetrics and gynecology clinics of North America. Philadelphia, W. Saunders, 1993:533-562.
42. Brossard Y. Surveillance et traitement anténatal des incompatibilités fœtomaternelles érythrocytaires. In : Wechsler B, Janse-Marec J, Pećhère JC, eds. Pathologies maternelles et grossesse. Paris : Medsi/McGraw-Hill, 1988:555-67.
43. Grannum PA. Ultrasound examination of the placenta. Clin Obstet Gynecol 1983;10:459-73.
44. DeVore GR, Mayden K, Tortora M, Berkowitz RL, Hobbins JC. Dilatation of the ombilical vein in rhesus hemolytic anemia : a predictor of severe disease. Am J Obstet Gynecol 1981;141:464-6.
45. Nicolaides KH, Fontanarosa M, Gabbe SG, Rodeck CH. Failure of ultrasonographic parameters to predict the severity of fetal anemia in rhesus isoimmunization. Am J Obstet Gynecol 1988;153:920-6.
46. Chitkara U, Wilkins I, Lynch L, Mehalek K, Berkowitz RL. The role of sonography in assessing severity of fetal anemia in Rh- and Kell-isoimmunized pregnancies. Obstet Gynecol 1988;71:393-8.
47. Frigoletto FD, Greene MF, Benacerraf BR, Barss V, Saltzman D. Ultrasonographic fetal surveillance in the management of the isoimmunized pregnancy. N Engl J Med 1986;315:430-2.
48. Rightmire D, Nicolaides KH, Rodeck CH, Campbell S. Fetal blood velocities in Rh isoimmunization: Relationship to gestational age and to fetal hematocrit. Obstet Gynecol 1986;60:233-6.
49. Copel JA, Grannum PA, Green J, Belanger K, Hobbins JC. Pulsed Doppler flow-velocity waveforms in the prediction of fetal hematocrit of the severely isoimmunized pregnancy. Am J Obstet Gynecol 1989;161:341-4.
50. Mari G, Moise K, Deter R, Kirshon B, Stefos T, Carpenter R. Flow velocity waveforms of the vascular system in the anemic fetus before and after intravascular transfusion for severe red blood cell alloimmunization. Am J Obstet Gynecol 1990;162:1060-4.
51. Mari G, Moise K, Deter R, Carpenter R. Doppler assessment of renal blood flow velocity waveforms in the anemic fetus before and after intravascular transfusion for severe red cell alloimmunization. J Clin Ultrasound 1991;19:15-9.
52. Hecher K, Snijders R, Campbell S, Nicolaides KH. Fetal venous, arterial, and intracardiac blood flows in red blood cell isoimmunization. Obstet Gynecol 1995;85:122-8.
53. Steiner H, Schaffer H, Spitzer D, Batka M, Graf A, Staudach A. The relationship between peak velocity in the fetal descending Aorta and hematocrit in Rhesus isoimmunization. Obstet Gynecol 1995;85:659-62.
54. Uzan M, Cynober E, Benard C. Guide pratique de Doppler en obstétrique. Paris, Masson, 1991.
55. Legarth J, Lingman G, Stangenberg M, Rahman F. Umbilical artery Doppler flow-velocity waveforms in Rhesus-isoimmunized fetuses before and after fetal blood sampling or transfusion. J Clin Ultrasound 1994;22:43-7.
56. Legarth J, Lingman G, Stangenberg M, Rahman F. Umbilical artery doppler flow-velocity waveforms and fetal acidbase balance in Rhesus-isoimmunized pregnancies. J Clin Ultrasound 1994;22:37-41
57. Copel J, Grannum PA, Belanger K, Green J, Hobbins JC. Pulsed doppler flow-velocity waveforms before and after intrauterine intravascular transfusion for severe erythroblastosis fetalis. Am J Obstet Gynecol 1988;156:768-4.
58. Bevis DCA. Blood pigments in haemolytic disease of the newborn. J Obstet Gynaecol Br Emp 1956;63:65.
59. Liley AW. Liquor amnii analysis in the management of the pregnancy complicated by Rhesus sensitization. Am J Obstet Gynecol 1961;82:1359-70.
60. Zipursky A, Bowman JM. Isoimmune hemolytic disease. In: Nathan DG, Oski A, eds. Hematology of infancy and childhood. 4th ed. Philadelphia, Saunders company, 1992:44-73.
61. Letsky EA. Haemolytic disease of the newborn. In: Hann IM, Gibson BE, Letsky EA, eds. Fetal and neonatal haematology. London, Baillère Tindall, 1989:94-119.
62. Hohlfeld P, Marty F, De Grandi P, Tissot JD, Bossart H. Le livre de l'interne: Obstétrique. Paris, Flammarion, 1993.
63. Nicolaides KH, Rodeck CH, Mibashan RS, Kemp J. Have Liley chart outlived their usefulness? Am J Obstet Gynecol 1986;155:90-4.
64. Daffos F, Capella-Pavlovsky M, Forestier F. A new procedure for fetal blood sampling in utero: Preliminary results of fifty-three cases. Am J Obstet Gynecol 1983;146:985-7.
65. Bennett PR, Le Van Kim Ç, Colin Y, Warwick RM, Path FR, Chérif-Zahar B, et al. Prenatal determination of fetal Rh type by DNA amplification. N Engl J Med 1993;329:607-10.
66. Fisk NM, Bennett PR, Warwick RM, Letsky EA, Welch R, Vaughan JI, et al. Clinical utility of fetal RhD typing in alloimmunized pregnancies by means of polymerase chain reaction on amniocytes or chorionic villi. Am J Obstet Gynecol 1994;171:50-4.
67. Rossiter JP, Blakemore Kd, Kickler TS, Kasch LM, Khouzami AN, Pressmann EK, et al. The use of polymerase chain reaction to determine fetal RhD status. Am J Obstet Gynecol 1994;171:1047-51.
68. Spence C, Maddalena A, Demers D, Bick D. Molecular analysis of the RhD genotype in fetuses at risk for RhD hemolytic disease. Obstet Gynecol 1995;85:296-8.
69. Dildy G, Jackson M, Ward K. Determination of fetal RhD status from uncultured amniocytes. Obstet Gynecol 1996;88:207-10.
70. Mannessier L, Dourieux S, Delsalle A, Huart JJ, Puech F. Groupage Rh par PCR sur cellules amniotiques. J Gynecol Obstet Biol Reprod 1995;24:827-8.
71. Crombach G, Picard F, Beckmann M, Tutschek B, Bald R, Niederacher D. Fetal rhesus D genotyping on amniocytes in alloimmunised pegnancies using fluorescence duplex polymerase chain reaction. Br J Obstet Gynecol 1997;104:15-9.
72. Le Van Kim C, Mouro I, Brossard Y, Chavinié J, Cartron J-P, Colin Y. PCR-based determination of Rhc and RhE status of fetuses at risk of Rhc and RhE haemolytic disease. Br J Haematol 1994;88:193-5.
73. Van den Veyver I, Chong S, Cota J, Bennett P, Fisk NM, Handyside A, et al. Single-cell analysis of the RhD blood type for use in preimplantation diagnosis in the prevention of severe hemolylic disease of the newborn. Am J Obstet Gynecol 1995;172:533-40.
74. Simpson JL, Elias S. Isolating fetal cells from maternal blood. Advances in prenatal diagnosis through molecular technology. JAMA 1993;270:2357-61.
75. Bennett PR, Warwick RM, Letsky EA, Fisk NM. Determination of fetal RhD type by DNA amplification from fetal skin following massive fetomatemal haemorrhage and intrauterine fetal death. Br J Obstet Gynecol 1994;101:636-7.
76. Nicolaides KH, Tnilaganathan B, Mibashan RS. Cordocentesis in the investigation of fetal erythropoiesis. Am J Obstet Gynecol 1989;1197:1197-200.
77. Pattison N, Roberts A. The management of severe erythroblastosis fetalis by fetal transfusion: Survival of transfused adult erythrocytes in the fetus. Obstet Gynecol 1989; 74:901-4.
78. Reece EA, Copel J, Scioscia AL, Grannum PA, DeGennaro N, Hobbins JC. Diagnostic fetal umbilical blood sampling in the management of isoimmunization. Am J Obstet Gynecol 1988;159:1057-62.
79. Seeds JW, Bowes WA. Ultrasound-guided fetal intravascular transfusion in severe rhesus immunization. Am J Obstet Gynecol 1986;154:1105-7.
80. Berkowitz RL, Chitkara U, Goldberg JD, Wilkins I, Chervenak FA. Intravascular transfusion in utero: the percutaneous approach. Am J Obstet Gynecol 1986;154:622-3.
81. Kanhai HM. Management of severe hemolytic disease with ultrasound-guided intravascular fetal transfusions. Vox Sang 1990;59:180.
82. Gibson BE. Transfusion in the fetus and newborn. In: Hann IM, Gibson BE, Letsky EA, eds. Fetal and neonatal haematotogy. London, Baillere Tindall, 1989:194-6.
83. Vomund SL, Witter SE. Advanced techniques for the treat-ment of severe isoimmunization. Am J Matem Child Nurs 1994;10:18-23.
84. Parkman R, Mosier D, Umansky I, Cochran W, Carpenter C, Rosen F. Graft-versus-host disease after intrauterine and exchange transfusions for hemolytic disease of the newborn. N Engl J Med 1974;290:359-63.
85. Naiman L, Punett H, Lischner H, Destiné M, Arey J. Possible graft-versus-host reaction after intrauterine transfusion for the Rh erythroblastosis fetalis. N Engl J Med 1969;281:697-701.
86. Jackson G, Scott JR. Alloimmune conditions and pregnancy. In: Stirrat G, Scott J, eds. Clinical obsterics and gynaecology: the immune system in disease. London : Baillère Tindall, 1992:541-63.
87. Daffos F, Capella-Pavlovsky M, Forestier F. Fetal blood sampling during pregnancy with use of a needle guided by ultrasound: A study of 606 consecutive cases. Am J Obstet Gynecol 1985;153:655-60.
88. Orlandi F, Damiani G, Jakil C, Bertolino O, Maggio A. The risks of early cordocentesis (12-21 weeks): Analysis of 500 procedures. Prenat Diagn 1990;10:425-8.
89. Pielet B, Socol M, MacGregor S, Ney J, Dooley S. Cordocentesis: An appraisal of risks. Am J Obstet Gynecol 1988;159:1497-500.
90. Feinkind L, Nanda D, Delke I, Minkoff H. Abruptio placentae after percutaneous umbilical cord sampling: A case report. Am J Obstet Gynecol 1990;162:1203-4.
91. Wilkins I, Mezrow G, Lynch L, Bottone E, Berkowitz RL. Amnionitis and life-threatening respiratory distress after umbilical blood sampling. Am J Obstet Gynecol 1989;160:427-8.
92. Nicolini U, Kochenour N, Greco P, Letsky EA, Johnson R, Contreras M et al. Consequences of fetomatemal haemorrhage after intrauterine transfusion. Br Med J 1988;297:1379-81.
93. Bowell BM, Selinger M, Ferguson JF, Giles J, MacKenzie IZ. Antenatal fetal blood sampling for the management alloimmunized pregnancies: Effect upon maternal anti-D potency levels. Br J Obstet Gynecol 1988;95:759-64.
94. Bowman JM, Pollock JM, Peterson LE, Harman CR, Manning FA, Menticoglou SM. Fetomatemal hemorrhage following funipuncture: Increase in severity of maternal redcell alloimmunization. Obstet Gynecol 1994;84:839-43.
95. MacKenzie IZ, Bowell BM, Castle BM, Selinger M, Ferguson JF. Serial fetal blood sampling for the management pregnancies complicated by severe rhesus(D) isoimmunization. Br J Obstet Gynecol 1988;95:753-8.
96. Donner C, Lambermont M, Karioun A, Paquet V, Vermeylen D, Rodesch F. Surveillance et traitement de l'allo-immunisation fœto-maternelle: Rôle de la cordocentèse. J Gynecol Obstet Biol Reprod 1994;23:892-7.
97. Grannum PA, Copel J, Moya F, Scioscia AL, Robert J, Winn H et al. The reversal of hydrops fetalis by intravascular intrauterine transfusion in severe isoimmune fetal anemia. Am J Obstet Gynecol 1988;150:14-9.
98. Harman CR, Bowman JM, Manning FA, Menticoglou SM. Intrauterine transfusion-intraperitoneal versus intravascular approach: A case-control comparison. Am J Obstet Gynecol 1990;162:1053-9.
99. Nicolini U, Nicolaidis P, Fisk NM, Tannirandom Y, Rodeck CH. Fetal blood sampling from the intrahepatic vein: Analysis of safety and clinical experience with 214 procedures. Obstet Gynecol 1990;76:47-53.
100. Antsaklis A, Papantoniou N, Mesoogitis S, Koutra P, Vintzileos A, Aravantinos D. Cardiocentesis : an alternative method of fetal blood sampling for the prenatal diagnosis of hemoglobinopathies. Obstet Gynecol 1992;79:630-3.
101. Gudson J, Moore V, Myrvik Q, Holyfield P. PromethazineHCL as an immunosuppressant. J Immunol 1972;108:1340-4.
102. Gudson J, Caudle M, Herbst G, Iannuzzi N. Phagocytosis and erythroblastosis. I. Modification of the neonatal response by promethazine hydrochloride. Am J Obstet Gynecol 1975;125:224-6.
103. Stenchever MA. Promethazine hydrochloride: Use in patients with Rh isoimmunization. Am J Obstet Gynecol 1978;130:665-68.
104. Gudson J. The treatment of erythroblastosis with promethazine hydrochloride. J Reprod Med 1981;26:454-8.
105. Caudle M, Scott JR. The potential role of immunosuppression, plasmapheresis, and desensitization as treatment modalities for Rh immunization. Clin Obstet Gynecol 1982;25:313-9.
106. Bierme SJ, Blanc M, Abbal M, Fournie A. Oral Rh treatment for severely immunised mother. Lancet 1979;1:604-5.
107. Powell LC. Intense plasmapheresis in the pregnant Rhsensitized woman. Am J Obstet Gynecol 1968;101: 153-70.
108. Fraser ID, Bennett Mo, Bothamley JE, Airth GR. Intensive antenatal plasmapheresis in severe Rhesus isoimmunisation. Lancet 1976;1:6-8.
109. Graham-Pole J, Barr W, Willoughby MLN. Continuous-flow plasmapheresis in management of severe rhesus disease. Br Med J 1977;1:1185-8.
110. Moya F, Grannum PA, Widness J, Clemons G, Copel J, Hobbins JC. Erytropoietin in human fetuses with immune hemolytic anemia and hydrops fetalis. Obstet Gynecol 1993;82:353-8.
111. Thilaganathan B, salseven D, Abbas A, Ireland R, Nicolaides KH. Fetal plasma erythropoietin concentration in red blood cell-isoimmunized pregnancies. Am J Obstet Gynecol 1993;167:1292-7.
112. Scaradavou A, Inglis S, Peterson P, Dunne J, Chervenak FA, Bussel J. Suppression of erythropoiesis by intrauterine transfusions in hemolytic disease of the newborn: Use of erythropoietin to treat the late anemia. J Pediatr 1993; 123:279-84.
113. Linch DC, Rodeck CH, Nicolaides KH, Jones HM, Brent L. Attempted bone-marrow transplantation in a 17-week foetus. Lancet 1986;ii:1453.
114. Thilaganathan B, Nicolaides KH. Intrauterine bone-marrow transplantation at 12 weeks' gestation. Lancet 1993; 342:243.
115. Smith C, Hammarström L. Intravenous immunoglobulin in pregnancy. Obstet Gynecol 1985;66:39-40.
116. Newland A, Boots M, Patterson K. Intravenous IgG for autoimmune thrombocytopenia in pregnancy. N Engl J Med 1984;370:261-2.
117. Bussel J, Berkowitz RL, McFarland J, Lynch L, Chitkara U. Antenatal treatment of neonatal alloimmune thrombocytopenia. N Engl J Med 1988;319:1374-8.
118. Rewal D. Intravenous gammaglobulin to prevent stillbirth in Rhesus incompatibility. Lancet 1985;2:208.
119. Porter F, Silver R, Jakson M, Branch W, Scott J. Intravenous immune globulin in the management of severe Rh D hemolytic disease. Obstet Gynecol Surv 1997;52:193-7.
120. Dooren M, Engelfriet P. Protection against Rh D-haemolytic disease of the newborn by a diminished transport of maternal IgG to the fetus. Vox Sang 1993;65:59-61.
121. Marguilies M, Voto L, Mathet E. High-dose intravenous IgG for the treatment of severe Rhesus alloimmunization. Vox Sang 1991;67:181-9.
122. De la Camara C, Arrieta R, gonzalez A, Iglesias E, Omen̄aca F. High-dose intravenous immunoglobulin as the sole prenatal treatment for severe Rh immunization. N Engl J Med 1988;318:519-20.
123. Berlin G, Selbing A, Ryden G. Rh haemolytic disease treated with high-dose intravenous immunoglobulin. Lancet 1985;1:1153.
124. Scott JR, Branch DW, Kochenour N, Ward K. Intravenous immunoglobulin treatment of pregnant patients with recurrent pregnancy loss caused by antiphospholipid antibodies and Rh immunization. Am J Obstet Gynecol 1988; 159: 1055-6.
125. Caine ME, Mueller-Heubach E. Kell sensitization in pregnancy. Am J Obstet Gynecol 1986;154:85-90.
126. Leggat HM, Gibson JM, Barren SL, Reid MM. Anti-Kell in pregnancy. Br J Obstet Gynecol 1991;98:162-5.